As a secreted fluid, the state of tear glycosylation is particularly important in the role of immunity of the ocular surface. Tears are a valuable source of non-invasive biomarkers for disease and there are continued efforts to characterize their components thoroughly. In this study, a small volume of basal tears (5 μL) was collected from healthy controls, patients with diabetes without retinopathy and patients with diabetes and retinopathy. The detailed N-and O-linked tear protein glycome was characterized and the relative abundance of each structure determined. Of the 50 N-linked glycans found, 89% were complex with 50% containing a bisecting N-acetylglucosamine, 65% containing a core fucose whilst 33% were sialylated. Of the 8 O-linked glycans detected, 3 were of cores 1 and 5 of core 2 type, with a majority of them being sialylated (90%). Additionally, these glycan structures were profiled across the three diabetic disease groups. Whilst the higher abundant structures did not alter across the three groups, only five low abundance N-linked glycans and 1 O-linked glycan did alter with the onset of diabetes mellitus and diabetic retinopathy (DR). These results suggest the conservation of glycan types on basal tear proteins between individuals and point to only small changes in glycan expression on the proteins in tears with the development of diabetes and DR.
Introduction
The prevalence of diabetes is growing world-wide and it is projected that by 2030 4.4% of the world's population will have some form of diabetes (Wild et al. 2004 ). Development of retinopathy, a vision impairing sequela of the disease, where lesions occur in the retina due to microvascular changes, is a common complication of diabetic patients affecting up to a third of all patients with the disease (Ding and Wong 2012) . The abnormal vasculature can ultimately rupture into the neighboring vitreous of the eye causing loss of vision and at its most severe; the scarring of such events can lead to retinal detachment.
While treatment for retinopathy is available, the availability of a diagnostic technology that can detect the disease early in its development is lacking (Koss et al. 2012) . Currently, diagnosis is dependent upon the clinical presentation of diabetic retinopathy (DR), at which stage maturation of the disease and possible damage to the retinal tissue is significant. Over the last decade, protein biomarkers for ocular diseases have been sought in human tears (Lemp 1995; Herber et al. 2001; Grus et al. 2002 Grus et al. , 2005 . As a non-invasive source of biomarkers, tear fluid is easily accessible. Additionally, tear fluid can come in contact with the epithelium of the eye and thereby come in contact with blood and its associated proteins via leakage through conjunctival blood vessels .
Clinical evidence detailing tear film instability corresponding with ocular disease is well documented (Goebbels 2000; Grus et al. 2002; Foulks and Bron 2003; Guzman-Aranguez et al. 2009 ). Herber et al. (2001) demonstrated a significant increase in tear film global protein content in diabetic patients. High-performance liquid chromatography analysis has shown increased abundance of secretory immunoglobulin A (sIgA) and lysozyme in diabetic and DR patients, respectively, and a decrease in the amount of lipocalin in DR patients, when compared with healthy controls (Yu et al. 2008) . Additionally, Yu et al. demonstrated that onset of diabetic proliferative retinopathy decreased tear film function and the concentration of lactoferrin and lipocalin. On the other hand, apolipoprotein A-1 concentrations have been reported to increase with development of both diabetes and DR (Kawai et al. 2002) . The presence of advanced glycation end products on tear film proteins have also been demonstrated in tears of DR patients, with lactoferrin being particularly susceptible to glycation . There is also an increase in the level of glycosaminoglycans with diabetic patients (Moschos et al. 2008) . However, the overall glycosylation status of the tear film has not been comprehensively characterized in healthy people or in patients with diabetes. Schulz et al. (2002) has characterized the O-linked glycosylation of deleted in malignant brain tumor (DMBT)-1 from human tears whilst Guzman et al. (2009) has investigated the O-linked glycome of the conjunctival epithelium of the eye Moschos et al. 2008; Guzman-Aranguez and Argueso 2010) . Recently, Vieira et al. (2012) compared the expressed protein-linked N-and O-glycans in reflex tears collected by bright light stimulation and saliva from controls and patients with ocular rosacea. The paper reports in general higher fucosylation of the N-glycans and higher sulfation of the O-glycans in tears and saliva from ocular rosacea patients compared with controls. Only compositional data was described. Ozcan et al. (2013) used pooled patient tear samples to identify the structures of the O-glycans in more detail.
In the current study, the comprehensive glycomic profile of basal human tears is described and the extent of individual variation is shown. Additionally, a comparison between the glycomic profiles of tears of healthy individuals and of patients with diabetes with or without retinopathy is made.
Results

Characterization of tear glycans
N-and O-Linked alditols released from tear glycoproteins from five healthy subjects were separated using a PGC column and analyzed by liquid chromatography (LC)-ESI-IT-MS and tandem mass spectrometry (MS/MS). PGC chromatography can efficiently separate isomers and isobaric structures of glycans in a reproducible manner (Thomsson et al. 1999; Jensen et al. 2012; Kolarich et al. 2012) . Furthermore, specific fragment ions obtained in the tandem mass spectra negative ion mode can be diagnostic of certain glycan structural features (Harvey et al. 2008; Everest-Dass et al. 2013 ). In addition, sequential exoglycosidase treatment of the N-glycans was further used to validate these structural features (Table I) .
Negative ion fragmentation of two distinct N-glycans: (i) a core fucosylated bisecting agaloactosylated biantennary glycan and (ii) a core fucosylated biantennary glycan with a type 2 H-antigen in the 6-arm is shown in Figure 1 . Specific feature ions generated from the negative mode fragmentation enabled the identification of these N-glycan features. For example, The Z 1 ion of m/z 350 1− from both the spectra are confirmation of the presence of the chitobiose core fucose. ions have been previously reported to be diagnostic for the composition of the N-glycan 6-antenna (Harvey et al. 2008) , and these were found to give prominent signals in the spectra of glycans without a bisecting N-acetylglucosamine (GlcNAc) residue (Figure 1 ). The D ion arises from the loss of chitobiose core (C ion cleavage between Manβ1-4GlcNAc), and the Z ion cleavage between Manα1-3Man forming the 3-antennae; thus, the D-ion mass corresponds to the composition of the 6-arm antenna plus the two remaining branching core mannoses. In Figure 1B , the N-glycan 6-antenna monosaccharide composition was identified from ions m/z 834. The additional loss of the bisecting β1-4-linked GlcNAc gives rise to the D-221 ion in negative ion fragment spectra of N-glycans and has been found to be diagnostic for bisecting N-linked structures (Harvey et al. 2008) . In Figure 1A , the tandem MS of the bisecting structures of m/z 832. indicates the successful removal of the terminal sialic acids in all three isomers. Similarly, after exoglycosidase treatment of the α(2-3)-specific sialidase, the EIC of m/z 1111.4 2− shows the presence of only the early eluting 49.1 min isomeric glycan. The action of these two sialidases of varying specificity enables the sialic acid linkage identification of the disialylated biantennary N-glycan of the three isomers as α(2-6) linked (49.1 min), α(2-6) and α(2-3) linked (51.7 min) and α(2-3) linked (54.8 min), respectively. Specific exoglycosidases were also used to identify the galactose β1-3 or β1-4 linkage in LacNAc scaffolds. Monitoring the EIC of a typical N-glycan after desiaylation such as the bianntenary core fucosylated N-glycan of m/z 893.3 2− ( Figure 2B) shows only a single prominent peak signifying the presence of only one type of galactose linkage. The galactose linkage is identified as β1-4 linked as both the β(1-3,4) galactosidase and the β(1-4)-specific galactosidase completely remove the terminal galactose residues from the bianntenary core fucosylated N-glycan ( Figure 2B ). The resolution of complex glycan isomers using the combination of sequential exoglycosidase treatment and negative ion tandem MS is further illustrated in Figure 3 . The negative ion tandem MS fragmentation of the four isomers ((Hex) 5 (HexNAc) 4 (Deoxyhexose) 2-(NeuAc) 1 ) of m/z 1112 2− eluting at 49.1, 54.3, 57.3 and 60.9 min is shown in Figure 3 . Through the action of the α(2-3,6,8,9) sialidase and the α(2-3)-specific sialidase, the 49.1 and 54.3 min isomers were observed to contain the α2-6-linked sialic acid while the 57.3 and 60.9 isomers contained the α2-3-linked sialic acid (data not shown). Further characterization of fucose and sialic acid location on the N-glycans was determined from the tandem MS fragmentation ions ( Figure 3 ). All the isomers contained the Y 1 (m/z 368 1− ) and/or the Z 1 ion (m/z 350 1− ) stipulating core fucosylation. The C and B Figure 3A and B). The combination of these fragment ions and exoglycosidase treatment enabled the differentiation and identification of these four isomers differing in sialic acid and fucose linkage and antennae location. A total of 50 N-linked glycans released from tear glycoproteins were characterized. Figure 4 and Table I show the relative abundance of the global profile of N-linked glycans expressed in healthy tears (n = 5). The area under the EIC of each glycan mass was used to calculate the percentage of the total EIC of all the glycans identified in the analysis. The majority (89%) of the N-glycans were complex type glycans, with 6% high mannose and 5% hybrid type glycans. Most (65%) of the N-glycans were core fucosylated, 33% were sialylated and 50% of all N-linked structures had a bisecting GlcNAc. Only 2% of the structures were disialyated and only one core fucosylated glycan had an antenna containing a terminal Lewis x epitope fucosylation (at 0.5% relative abundance).
Although only 3 of the 8 O-linked glycans were core 1, they comprised 92.2% of the total relative abundance of O-glycans ( Figure 5 ). The majority (90%) of the O-linked glycans were sialylated. The negative ion fragmentation of the O-glycans was also characterized similarly to the N-glycans in identifying specific structural feature ions. The Supplementary data, Figure S2 were determined to differ based on the galactose linkage to the N-acetylglucosamine in the lactosamine residue. The low abundance of these structures did not permit us to sequentially confirm the galactose linkage by β1-3/β1-4-specific galactosidases. Although the tandem MS of the two spectra are quite identical with very similar structural feature ions, they can be resolved into type 2 and type 1 linkages based on fragmentation of the prominent 0,2 A cross-ring ion of m/z 554.9 1− as they have been previously observed in type 2-specific linkages (Everest-Dass et al. 2013) . The ion at m/z 364 1− is also only observed in the type 2-linked isomer corresponding to the mass of a LacNAc residue. This observation is consistent with our previous studies where the C3 linkage to the GlcNAc is labile relative to the C4 linkage, albeit in neutral structures (Everest-Dass et al. 2013) . Although mucin type O-glycans are reported mainly to contain sialic acid linked to terminal galactose, we confirmed this linkage using α2-3 sialidase treatment as indicated in Table II Figure S3 ) were found to be quite similar; the galactose linkage to the type 2 core GlcNAc was unable to be determined due to the lack of specific fragment ions. A noticeable difference was the presence of the 0,4 A ion at m/z 715 1− in Supplementary data, Figure S3B .
This cleavage is between C-4 and C-5 of the reducing end GalNAcol and can aid in determining the composition of the substituents of the C-6 linkage (Everest-Dass et al. 2013) . In addition, the B 3 ion at m/z 655 1− (Supplementary data, Figure S3B ) corresponds to a Neu5Ac-Gal-GlcNAc composition while the low abundant Z 1 ion at m/z 657 1− (Supplementary data, Figure S3A ) corresponds to Neu5Ac-Gal-GalNAcol. Consequently, the isomer eluting at 32.4 min has the α2-3-linked sialic acid to the C-3 branch of the reducing end GalNAcol and the 34.4 min isomer has the α2-3-linked sialic acid on the C-6 branch.
The only neutral O-linked glycan structure was the trisaccharide of m/z 530 1− comprising the H-antigen. Although the ABO blood group Figure S4 ) contained a sialylated Lewis x/a antigen (fragment ion m/z 819 1− , Supplementary data, Figure S4 ) on the C-6 branch of the core 2 glycan ( Figure 5 and Table II ).
Changes to lower abundance glycans occur with onset of diabetes mellitus and DR
Tear samples were collected from patients with diabetes without retinopathy (diabetes mellitus, DM) (n = 5) and diabetic patients with DR (n = 5) and from healthy control (CON) individuals (n = 5). The proteins were separated by methanol/chloroform/acetone partitioning of 5 µL of tears. The N-and O-glycans were released from the proteins and were analyzed using the aforementioned methodology. To measure glycan differences between the diseased states, the relative abundance of the area under the EIC peak of each glycan mass was determined. Differences for each identified glycan were assessed by analysis of variance on log-transformed relative abundances with analysis of variance P-value <0.05. The P-values were adjusted first to account for multiple testing using the Benjamini and Hochberg false discovery rate method. Changes to the glycomic N-linked profile with the onset of DM and DR were observed, albeit only amongst the relatively low abundance (<5%) glycans. Five glycans were identified to have altered statistically in abundance between healthy, DR and DM patients ( Figure 6 ). There was an increase in the abundance of a sialylated hybrid glycan (m/z 864.4 2− , retention time, RT = 49.3 min; 0.05 ± 0%, DR 0.05 ± 0%) was significant in diabetes with or without retinopathy complications. Changes were also observed in one O-glycan on tear glycoproteins with the onset of DR (Figure 6 ). The relative abundance of a disialyated core 2 glycan of (m/z 665.2 2− , RT = 34.1 min, P = 0.03; Con 0.4 ± 0.2%, DM 0.8 ± 0.5%, DR 3.9 ± 1.9%) was increased with the onset of DR. Interestingly, only the type 2-linked isomer of m/z 665.2 2− eluting at 34.1 min showed a significant change in diabetic tears.
Discussion
This study employed mass spectrometric techniques to characterize the tear protein glycome in detail and explored the diagnostic potential of tear glycans to differentiate DM and the common complication of DR. Tears are secreted from three primary sources; the outer lipid layer is secreted from the meibomian gland, the lacrimal gland secretes the aqueous phase whilst the conjunctival epithelium contributes the mucin layer to the tear film. Tears may be collected directly from the open-eye when they are called basal tears, or after stimulating the tear reflex response, when they are called reflex tears. The protein component of these different tear types is known to be different; for example, the levels of sIgA decreases in concentration from basal to reflex tears (Fullard and Snyder 1990; Fullard and Tucker 1991) .
Other tear proteins such as lactoferrin, lipocalin-1 and lysozyme do not appreciably change their concentration in basal or reflex tears (Fullard and Snyder 1990; Fullard and Tucker 1991) . For use as a diagnostic fluid, we chose to collect and compare the glycome from basal tear samples. As tears represent a heterogenous mixture of secreted proteins from different cellular origins, it is anticipated that diseases of the ocular region may be reflected in the changes to the protein and glycosylation status of the tear film. The attraction of using tears as a diagnostic fluid is attributable to the high protein concentration of tears (∼10 mg/ mL) and the relatively non-invasive nature of its collection. Despite this, the challenge of this investigation was the small volume (∼5 µL) of fluid able to be collected from each individual with minimal discomfort and without stimulation of reflex-tear production. This study thus characterized the composition, structures and normalized abundances of N-and O-linked glycans that were able to be analyzed by release from the proteins in 5 µL of basal tears collected from five individuals without disease and with DM or DR.
The 50 N-linked glycans were structurally characterized as complex glycans, a majority of which were fucosylated and had bisecting GlcNAc. Six of the seven O-glycans seen in the basal tears were core 2 O-glycans. sIgA, lactoferrin and lipocalin are at high concentration in the tear film and these proteins are densely glycosylated (Fullard and Tucker 1991; Royle et al. 2003; Sack et al. 2003; You et al. 2010; Yu et al. 2011) and therefore contribute to the majority of the glycans observed in the tear glycome in this study. The glycosylation of tear film lipocalin-1 has not been analyzed. The expression of bisecting glycans is high in sIgA (i.e. a major glycoprotein in both tears and saliva) representing ∼75% of the sIgA glycosylation (Royle et al. 2003) . Interestingly, studies to profile the N-glycome of saliva has found a high abundance of bisecting N-linked structures (Everest-Dass et al. 2012), thus suggesting a possible role of bisecting N-glycan structures in secreted fluids such as tears and saliva that affect the innate immunity of the host.
The current study has shown that the degree of sialylation in tears (33 and 90% in the tear N-and O-linked glycome, respectively) is relatively high compared with that of other secreted fluids such as saliva (12.8 and 15.2% of the N-and O-linked saliva glycome, respectively) (Everest-Dass et al. 2012) . Sialic acid on glycoproteins may confer several biological properties including receptors for bacterial binding to host proteins (Nakano et al. 2001 ). In the context of tearsecreted soluble proteins, bacterial binding to these may be associated with clearance from the ocular surface. Recent studies have also suggested that high sialylation may increase anti-inflammatory activity, which is extremely important for normal functioning of the eye (Beck et al. 2008) . Vieria et al. (2012) show the presence of highly fucosylated N-glycan compositions proposed to have 1-7 fucose residue masses and highly singly sulfated O-glycan compositions of saliva and tears from control and ocular rosacea patients, but it is unclear as to which compositions were found in tears alone. Our study found a high fucosylation (65%) of the N-glycans but in contrast these were determined to be mainly core fucosylated structures and a few terminally fucosylated structures carrying the H-type 2 and the Lewis x/a antigens. The increased sulfation of tear O-linked oligosaccharides that was reported to occur with the onset of ocular rosacea in the Vieria et al. (2012) study was most evident in their study in saliva (increase of 44 structures), whereas only three sulfated O-glycan compositions were seen in tears from these patients; no sulfated O-glycans were seen in the control tears. In our study of tear glycans from healthy, DR or DM patients no sulfation was detected, or if present was below the level of detection. In another report, Schulz et al. (2002) identified 46 O-glycans from DMBT-1, a major tear mucin-like glycoprotein separated from 20 μL of human reflex tears. The 8 O-linked glycan structures found in our study on the global basal tear glycome were the highly abundant structures on reflex-tear-derived DMBT-1 protein . Due to the relatively low concentration of soluble mucins in tears (Ellingham et al. 1999) , it is possible that by using only 5 µL of tears we were unable to find all the O-linked glycan structures previously reported in tears or on purified DMBT-1. Only five low abundance N-glycans and 1 O-glycan significantly changed in patients with diabetes or DR. Whether or not these changes are related to specific proteins remains to be validated. Torok et al. (2013) recently profiled the proteomic changes to the tear film between healthy controls, diabetic patients and diabetic patients with proliferative and non-proliferative stages of retinopathy and found that with the progression of the disease, the overall protein concentration decreased. However, the relative amounts of some proteins such as lipocalin-1, lactoferrin, lacritin, lysozyme, lipophilin and immunoglobulin lambda chain increased in tears of patients with developed retinopathy. Indeed, glycomic changes could be affected by such proteomic changes to the tear film.
In conclusion, the N-and O-linked glycome was analyzed on a small volume of basal tears (5 µL) from individuals. There was a marked conservation of the glycan structures on tear proteins between individuals and an indication of changes occurring to low abundance (<5%) glycans in the global profile of tear proteins with onset of diabetes or DR. Further investigation into whether these changes occur in the glycosylation of specific tear proteins that also alter in diabetes will improve the power of using tears as a diagnostic for the progressive stages of this disease.
Methods
Tear collection
All experimental protocols complied with the Declaration of Helsinki for experimentation on Humans (declared in 1975) and revised in 1983, and institutional ethics committee approval was granted. Tears were collected from healthy CON (n = 5), patients with diabetes mellitus without retinopathy (DM, n = 5) and patients diagnosed with diabetes with retinopathy (DR, n = 5). Basal tears were collected from patients at the First Hospital Affiliated to Medical College, Xi'an Jiaotong University, Xi'an, People's Republic of China. Patient data were also collected with reference to their hospital records. Tears were collected using a blunt glass capillary tube from the outer canthus of the eye. Informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study. Routinely, ∼5 µL tears were collected from each subject. Tears were stored at −80°C. Patients were sex and aged matched to healthy controls. Protein concentration was estimated at ∼8-10 μg/μL (Fullard and Snyder 1990; Fullard and Tucker 1991; ).
Sample preparation
Tears (5 µL) were precipitated via methanol/chloroform/acetone extraction (Wessel and Flugge 1984) and dried. Precipitates were suspended in 10 µL of 4 M urea. Five 2 µL volume of the resuspended pellets were spotted on a dot blot to anchor the proteins to a solid support prior to glycan release.
N-and O-linked glycan release for mass spectrometry analysis
N-and O-linked glycans were released from tear glycoproteins according to previously described methods (Wilson et al. 2002; Jensen et al. 2012; Kolarich et al. 2012) . Triplicate samples (∼100 μg) of tear proteins were immobilized by dot blotting on to a primed Immobilon-P Abundances of each glycan are relative to the measured area under the curve as determined by the EIC for each glycan. SDs are derived from n = 5. Exoglycosidase enzymes were used to confirm the linkages of the sialic acid (α2-3/6) in N-and O-glycans, and the terminal fucose (α1-3/4) and galactose (β1-3/4) linkage in N-glycans. polyvinylidene fluoride (PVDF) membrane (Millipore). The N-linked glycans were released by incubation with 3 U of peptide-N glycosidase F (PNGase F) (Flavobacterium meningosepticum, Roche, Basel, Switzerland), pH 8.0, overnight at 37°C. After acidification with 100 mM NH 4 COOH, pH 5 (final concentration 15 mM) for 60 min at room temperature, the samples were dried to in a vacuum centrifuge and were reduced with 20 µL of 1 M NaBH 4 in 50 mM KOH at 50°C for 3 h. The reduction was quenched with 1 µL glacial acetic acid and the N-linked glycan alditols were desalted as described below. O-Linked glycans were released from the PVDF membrane spots after PNGase F digestion via reductive β-elimination by incubating overnight with 20 µL of 0.5 M NaBH 4 in 50 mM KOH at 50°C. The reduction was quenched with 1 µL glacial acetic acid.
Desalting glycans
The released glycans were desalted using cation-exchange columns comprising 30 µL AG50W-X8 cation-exchange resin (Bio-Rad, Hercules) packed on top of a C18 StageTip Frit. Residual borate was removed by the addition of methanol (×5) and drying under vacuum. The glycans were resuspended in 10 µL of milli-Q water and subjected to PGC-LC-ESI-MS/MS separation and analysis.
Exoglycosidase treatment of the released glycans
Aliquots of reduced N-and O-glycans released from the tear glycoproteins were digested with an array of exoglycosidase enzyme combinations, following the manufacturer's recommended concentrations in 50 mM sodium acetate incubation buffer, pH 5, at 37°C for 12 h. Enzymes were removed by carbon-cleanup as previously described before being analyzed by PGC-LC-ESI-MS/MS as above .
The enzymes used were as follows: Streptococcus pneumoniae sialidase (α2-3); Arthrobacter ureafaciens sialidase (α2-3, 6, 8); almond meal α-fucosidase (α1-3, 4); bovine testes β galactosidase (β1-3, 4, 6), Streptococcus pneumoniae β galactosidase (β1-4) purchased from Prozyme (Carlsbad, CA).
Mass spectrometry
N-and O-Linked glycan alditols were separated using an Agilent 1100 capillary LC (Agilent Technologies, Santa Clara, CA) and analyzed using an Agilent MSD, three-dimensional Ion-trap XCT mass spectrometer coupled to the LC. Separation was performed on a Hypercarb Porous Graphitized Carbon column (PGC, 5 µm particle size, 100 × 0.18 mm, Hypercarb, Thermo Scientific) across an 85 min gradient with a constant flow rate of 2 µL/min using a linear gradient up to 45% (v/v) CH 3 CN in 10 mM NH 4 HCO 3 . O-Linked glycans were separated on the same column using a 45-min gradient of 0-90% (v/v) CH 3 CN in 10 mM NH 4 HCO 3 .
ESI-MS was performed in negative ion mode with two scan events; MS full scan with mass range 100-2000m/z and data-dependent MS/ MS scan after collision-induced dissociation of the top two most intense precursor ions.
Supplementary data
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